European Hematology Association 2024 Congress
Find critical updates in hematologic oncology from the European Hematology Association 2024 Congress, held from June 13-16, 2024, in Madrid, Spain.
Certain predictive markers may help identify patients who "experience significant benefits" from upfront use of this therapy.
Lorna Warwick, CEO of Lymphoma Coalition, discusses how nurses can strengthen bonds with patients through communication.
Erik Aerts, RN, shares why it was critical for nurses to attend the EHA 2024 Congress in Madrid, Spain.
Mairéad Ní Chonghaile, RGN, BNS, MSc, speaks about the importance of staying current on the latest updates in the field.
Researchers presented real-world data on the cGVHD treatment during the EHA 2024 Congress.
Lorna Warwick discusses the important role that nurses serve in ensuring patients receive care and information.
Hear expert insights on managing treatment for these patients and the key signs and symptoms to monitor.
Valeria Santini, MD, shares her insights during the European Hematology Association 2024 Congress.
Nearly all patients in the study had steroid-dependent chronic GVHD, and nearly half had severe chronic GHVD.
An MPN program director discusses the key elements that oncology nurses should keep in mind when observing these patients.
Ms. Warwick discusses what nurses should know about results from the coalition's global patient survey.
A real-world study presented at the EHA 2024 Congress provided insights on patient and caregiver experiences.
Nursing managers should be aware of how standard infection prevention behaviors among nurses may vary.
Advertisement
Advertisement
